<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:admin="http://webns.net/mvcb/"
	xmlns:photo="http://www.pheed.com/pheed/"
	xmlns:media="http://search.yahoo.com/mrss"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<channel>
	<title>wystanfiさんの新着動画</title>
	<link>https://liaoningmovie.net/member?mid=82299309</link>
	<description><![CDATA[]]></description>
	<dc:language>ja</dc:language>
	<dc:creator>FC2, Inc.</dc:creator>
	<dc:date>Fri, 19 Nov 2010 03:16:48 +0900</dc:date>
		
	<item>
		<title>Advanced Cell Tech phase 1 trading volumes remain high in the stem cell company&#039;s stock </title>
		<link>https://liaoningmovie.net/content/20101119U3T4qPUL/</link>
		<description><![CDATA[<a href="https://liaoningmovie.net/content/20101119U3T4qPUL/"><img src="http://www.veoh.com/up/thumb/" /></a><br />Bill Caldwell, Chairman and CEO of Advanced Cell Technology, tells Proactive Investors that while the stem cell company is on the verge of major breakthroughs he is confident it has sufficient cash to get through the next two years. He is also encouraged by the high trading volumes in ACTC stock and says this, combined with the stock price, represents nothing more than an option with no expiration date for investors.]]></description>
		<dc:subject>ニュース 時事 ブログ</dc:subject>
		<dc:date>Fri, 19 Nov 2010 03:16:48 +0900</dc:date>
	</item>

		
	</channel>
</rss>
